BLOOD REVIEWS is a highly regarded journal published by Churchill Livingstone, specializing in the fields of Hematology and Oncology. With an impressive Q1 ranking in both disciplines and placing in the top 10% of its peer categories according to Scopus metrics, it provides an essential platform for the dissemination of cutting-edge research and reviews pertaining to blood disorders and cancer treatment. Since its inception in 1987 and continuing through 2024, the journal has established itself as a cornerstone for healthcare professionals, researchers, and students who seek to advance their understanding of hematologic and oncologic topics. While not an open-access journal, BLOOD REVIEWS retains a reputation for delivering high-quality, peer-reviewed articles that foster dialogue and innovation within the scientific community. For those in the United States and beyond, the journal serves as a vital resource, housed at the Journal Production Department in Edinburgh, Scotland, ensuring accessibility and a global reach in its critical academic contributions.

PHLEBOLOGIE is an esteemed journal published by GEORG THIEME VERLAG KG, serving as a critical platform for the dissemination of research in the field of Cardiology and Cardiovascular Medicine. Since its inception in 1991, the journal has consistently provided a comprehensive range of articles that explore the complexities of vascular health, offering insights into innovative treatments, diagnostic advancements, and emerging trends. Although currently not available as an Open Access publication, PHLEBOLOGIE maintains an impactful presence in the academic community, evident in its 2023 Scopus ranking as Q3 within its category and a percentile standing of 25%. Residing in Germany, PHLEBOLOGIE aims to bridge the gap between research and practice, appealing to researchers, clinicians, and students alike by fostering a deeper understanding of vascular conditions and their management.

Handchirurgie Mikrochirurgie Plastische Chirurgie, published by THIEME MEDICAL PUBL INC, is a distinguished journal serving the fields of orthopedics, sports medicine, and surgery. Established in 1982, this peer-reviewed publication has gained recognition for its contributions to the scientific discourse surrounding hand surgery, microsurgery, and plastic surgery. With an ISSN of 0722-1819 and an E-ISSN of 1439-3980, the journal feeds the intellectual curiosity of researchers and practitioners alike, providing a platform for innovative studies and advancements in surgical techniques. As of 2023, it holds a Q4 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Surgery, reflecting its growing importance and influence. Although not an open-access journal, it offers various subscription options to access cutting-edge research and clinical insights. With the continuous generation of high-quality and impactful content through 2024, this journal is an essential resource for those dedicated to enhancing surgical practices and patient outcomes.

Blood and Lymphatic Cancer-Targets and Therapy, published by DOVE MEDICAL PRESS LTD, is a vital open-access journal that has been disseminating crucial research and findings in the field of hematology and oncology since 2011. With its ISSN 1179-9889, this journal focuses on the latest therapeutic targets and innovative treatment strategies for blood and lymphatic cancers, contributing significantly to the advancement of knowledge and practice in this specialized area. Designed for researchers, healthcare professionals, and students alike, Blood and Lymphatic Cancer-Targets and Therapy aims to foster a deeper understanding of cancer biology and promote collaborative efforts leading to novel therapeutic interventions. The open-access model ensures that research findings are readily accessible to a global audience, underscoring the journal's commitment to enhancing patient care and fostering educational growth in the cancer domain.

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.

Pain Practice is an esteemed journal published by WILEY, focusing on the vital field of Anesthesiology and Pain Medicine. With an impressive impact factor reflected in its ranking of #30 out of 136 in its category, Pain Practice operates within the Q2 quartile, indicating its significant influence and contribution to research and clinical practices in managing pain. Established in 2004 and set to converge in 2024, this journal is dedicated to publishing high-quality, peer-reviewed articles that cover a wide range of topics related to pain management, therapeutic approaches, and novel interventions. Although it does not currently offer open access, it remains a crucial resource for professionals and researchers in the field, encouraging advancements in treatment methods and enhancing patient care in pain management.

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

Clinical Medicine Insights-Endocrinology and Diabetes, published by SAGE Publications Ltd, is a dynamic open-access journal dedicated to advancing the field of endocrinology and diabetes through high-quality research. Since its inception in 2008, this journal has become an essential resource for researchers, healthcare professionals, and students interested in the latest innovations and clinical practices in the realm of diabetes management and endocrine disorders. With an impressive 2023 JCR Q2 ranking in both Endocrinology, Diabetes and Metabolism and Internal Medicine, the journal serves as a pivotal platform for scholarly discussions, focusing on the convergence of clinical insights and therapeutic advancements. By offering an open-access model, the journal ensures that its articles are accessible to a global audience, thus promoting the dissemination of knowledge and best practices in the treatment of these critical health issues. The journal's commitment to excellence is reflected in its Scopus rankings, which position it among the noteworthy publications in the field. As it converges from 2009 to 2024, Clinical Medicine Insights-Endocrinology and Diabetes remains a cornerstone for impactful research, inspiring collaborations and serving as a vital reference for ongoing developments in patient care and treatment methodologies.

Oncology Reviews, founded in 2007 and published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to advancing knowledge in the field of oncology and cancer research. With an Impact Factor reflecting its robust engagement in scholarly discourse, this journal maintains a prestigious standing, earning a Q2 ranking in Oncology and a Q3 ranking in Cancer Research as of 2023. Notably, it is indexed in Scopus, where it ranks #118 in Oncology and #98 in Cancer Research, highlighting its global reach and significance. The journal's open-access policy, in effect since 2012, ensures that high-quality research is accessible to all, fostering collaboration and wellness improvements worldwide. This commitment to accessibility and dissemination of pivotal research makes Oncology Reviews an essential resource for researchers, healthcare professionals, and students eager to contribute to and stay abreast of the latest innovations in cancer treatment and research.

Seminars in Pediatric Surgery is a reputable journal published by Elsevier Science Inc, focusing on the dynamic and essential field of pediatric surgery. With an ISSN of 1055-8586 and E-ISSN 1532-9453, this journal is dedicated to advancing the knowledge and understanding of surgical practices in children, contributing valuable insights to both clinical and academic communities. Established in 1992, it has demonstrated its significance in medical education and research with a strong ranking in both the Q2 category for Pediatrics, Perinatology and Child Health and Surgery as of 2023. Additionally, its Scopus rankings reveal its reputable standing, placing it in the top 38% and 45% respectively among its peers in these specialties. Although the journal does not offer open access, it remains an essential resource for researchers, medical practitioners, and students wishing to stay abreast of innovative techniques, evolving practices, and groundbreaking research within pediatric surgery.